Clinical Trial Update: Boosting Osimertinib Blood Brain Barrier Penetration [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update from Maastricht University Medical Center describes efforts to boost brain penetration of osimertinib in non-small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TAGRISSO (osimertinib)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING